Filing Flows › Celularity (CELU) › Who owns the stock
Who owns Celularity (CELU) stock
38 funds reported Celularity (CELU) shares in their latest 13F filings, worth $3.2M in all. The largest holder is C V Starr ($1.6M). Last quarter 12 funds added to their stakes and 8 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| C V Starr | 764,069 | $1.6M | unchanged | 2026-06-30 |
| Vanguard Group | 676,650 | $751K | unchanged | 2025-12-31 |
| Vanguard Capital Management LLC | 621,105 | $371K | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 167,150 | $100K | decrease | 2026-06-30 |
| Citadel Advisors LLC | 99,054 | $59K | new | 2026-06-30 |
| Vanguard Fiduciary Trust | 79,874 | $48K | unchanged | 2026-06-30 |
| Biltmore Family Office, LLC | 35,000 | $47K | unchanged | 2026-09-30 |
| BlackRock | 76,359 | $46K | decrease | 2026-06-30 |
| Sky Investment Group LLC | 29,920 | $40K | new | 2026-09-30 |
| State Street | 57,830 | $35K | unchanged | 2026-06-30 |
| Northern Trust | 44,163 | $26K | unchanged | 2026-06-30 |
| IPG Investment Advisors LLC | 17,169 | $23K | unchanged | 2026-09-30 |
| HB Wealth Management, LLC | 31,915 | $19K | decrease | 2026-06-30 |
| Keynote Financial Services LLC | 29,920 | $18K | increase | 2026-06-30 |
| Jane Street Group, LLC | 28,713 | $17K | new | 2026-06-30 |
Celularity's latest quarter
Celularity, Q2 2026: revenue $5.4M (-5% year over year), operating margin -78.0%, net earnings $706K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CELU stock?
By the latest 13F filings: C V Starr ($1.6M); Vanguard Group ($751K); Vanguard Capital Management LLC ($371K); Geode Capital Management, LLC ($100K); Citadel Advisors LLC ($59K).
What is the short interest in CELU?
441,798 shares were sold short at the 2026-10-15 settlement, 12.91% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.